CoLucid Pharmaceuticals

PharmaceuticalsSeries CCambridge, US

Latest round

Series C

Last raised

Jan 2015

Total raised

$87M

Investors

10

About CoLucid Pharmaceuticals

Founded in 2005 and based in the US, CoLucid Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops remedies for migraines.

Who invested in CoLucid Pharmaceuticals

10 investors across 4 rounds

See all investors in CoLucid Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jan 13, 2015

    Amount

    $37M

    Investors

    Locked

  2. Series B

    Jul 1, 2008

    Amount

    $25M

    Investors

    Locked

  3. Series A

    Jan 17, 2006

    Amount

    $17M

    Investors

    Locked

  4. Series A

    Dec 31, 2005

    Amount

    $8.3M

    Investors

    Locked

Questions about CoLucid Pharmaceuticals

Who invested in CoLucid Pharmaceuticals?

CoLucid Pharmaceuticals has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has CoLucid Pharmaceuticals raised?

CoLucid Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did CoLucid Pharmaceuticals last raise money?

CoLucid Pharmaceuticals's most recent round on record is a Series C, in Jan 2015.

What does CoLucid Pharmaceuticals do?

Founded in 2005 and based in the US, CoLucid Pharmaceuticals, Inc.

Where is CoLucid Pharmaceuticals headquartered?

CoLucid Pharmaceuticals is headquartered in Cambridge, US.

Which VCs invest in companies like CoLucid Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at CoLucid Pharmaceuticals's stage. Their profiles are linked below.

Raising like CoLucid Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.